Panion & Bf Biotech Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 533.209 million compared to TWD 328.716 million a year ago. Operating income was TWD 82.760 million compared to TWD 11.354 million a year ago. Net income was TWD 74.327 million compared to net loss of TWD 7.581 million a year ago. Basic earnings per share from continuing operations was TWD 0.97 compared to basic loss per share from continuing operations of TWD 0.1 a year ago. For the half year, sales was TWD 907.258 million compared to TWD 669.321 million a year ago. Operating income was TWD 81.301 million compared to TWD 26.845 million a year ago. Net income was TWD 49.541 million compared to net loss of TWD 6.873 million a year ago. Basic earnings per share from continuing operations was TWD 0.65 compared to basic loss per share from continuing operations of TWD 0.09 a year ago.